Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,372 | 794 | 99.9% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,961 | 241 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,280 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $960.47 | 66 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $908.99 | 53 | $0 (2022) |
| Amgen Inc. | $867.77 | 71 | $0 (2024) |
| Lilly USA, LLC | $744.68 | 54 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $724.10 | 48 | $0 (2024) |
| PFIZER INC. | $702.34 | 62 | $0 (2024) |
| ABBVIE INC. | $311.08 | 22 | $0 (2023) |
| Merck Sharp & Dohme LLC | $286.27 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,504 | 85 | Novo Nordisk Inc ($405.11) |
| 2023 | $1,768 | 112 | Novo Nordisk Inc ($487.17) |
| 2022 | $1,624 | 108 | Novo Nordisk Inc ($323.05) |
| 2021 | $1,418 | 91 | Novo Nordisk Inc ($476.50) |
| 2020 | $858.75 | 59 | Janssen Pharmaceuticals, Inc ($147.08) |
| 2019 | $1,550 | 124 | Novo Nordisk Inc ($294.75) |
| 2018 | $1,439 | 114 | Novo Nordisk Inc ($443.76) |
| 2017 | $1,216 | 102 | Novo Nordisk Inc ($392.97) |
All Payment Transactions
795 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: DIABETES | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Obesity | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Respiratory | ||||||
| 10/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 09/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Bone Health | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $0.19 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 4,822 | 10,673 | $677,271 | $258,782 |
| 2022 | 43 | 4,610 | 9,566 | $626,349 | $243,876 |
| 2021 | 45 | 4,048 | 7,959 | $538,039 | $212,559 |
| 2020 | 38 | 2,508 | 6,203 | $469,586 | $168,442 |
All Medicare Procedures & Services
169 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 360 | 1,240 | $244,602 | $99,959 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 487 | $64,771 | $25,494 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 168 | 168 | $39,816 | $20,136 | 50.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 68 | 194 | $21,922 | $10,705 | 48.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 136 | 138 | $19,073 | $9,880 | 51.8% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 53 | 62 | $21,824 | $8,666 | 39.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 364 | 1,011 | $21,231 | $8,464 | 39.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $7,248 | $6,653 | 91.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 305 | 483 | $27,531 | $6,306 | 22.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 41 | 41 | $10,660 | $6,291 | 59.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 327 | 711 | $22,752 | $5,866 | 25.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 42 | 46 | $8,694 | $4,568 | 52.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 141 | 143 | $5,148 | $4,067 | 79.0% |
| 80076 | Liver function blood test panel | Office | 2023 | 297 | 477 | $15,264 | $3,801 | 24.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 152 | 397 | $16,674 | $3,546 | 21.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 206 | 206 | $9,476 | $3,486 | 36.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 200 | 413 | $14,455 | $3,131 | 21.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 22 | 22 | $3,190 | $2,878 | 90.2% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 297 | 475 | $13,775 | $2,798 | 20.3% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 281 | 423 | $12,690 | $2,684 | 21.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 137 | 137 | $10,823 | $2,318 | 21.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 98 | 185 | $7,955 | $1,755 | 22.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 85 | 103 | $7,519 | $1,669 | 22.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 39 | 43 | $3,397 | $1,611 | 47.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 78 | 78 | $7,176 | $1,476 | 20.6% |
About Dr. John Hale, M.D
Dr. John Hale, M.D is a Family Medicine healthcare provider based in Union City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104806413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hale, M.D has received a total of $11,378 in payments from pharmaceutical and medical device companies, with $1,504 received in 2024. These payments were reported across 795 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($11,372).
As a Medicare-enrolled provider, Hale has provided services to 15,988 Medicare beneficiaries, totaling 34,401 services with total Medicare billing of $883,658. Data is available for 4 years (2020–2023), covering 169 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Union City, TN
- Active Since 01/20/2006
- Last Updated 06/11/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1104806413
Products in Payments
- XARELTO (Drug) $876.19
- FARXIGA (Drug) $870.35
- Ozempic (Drug) $778.46
- TRINTELLIX (Drug) $539.20
- JARDIANCE (Drug) $486.43
- Saxenda (Drug) $464.26
- TRADJENTA (Drug) $450.96
- Rybelsus (Drug) $422.28
- Victoza (Drug) $364.21
- Otezla (Drug) $362.90
- BREZTRI (Drug) $358.46
- Wegovy (Drug) $330.27
- MOUNJARO (Drug) $329.50
- TRULICITY (Drug) $270.20
- Tresiba (Drug) $269.51
- CHANTIX (Drug) $235.07
- RYBELSUS (Drug) $228.03
- EVENITY (Biological) $220.69
- LYRICA (Drug) $219.83
- Aimovig (Biological) $182.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Union City
Dr. Jerry Jurado, M.d, M.D
Family Medicine — Payments: $63,292
Francisco Gonzalez, Md, MD
Family Medicine — Payments: $14,250
John Clendenin, M.d, M.D
Family Medicine — Payments: $11,619
William Stone, M.d, M.D
Family Medicine — Payments: $11,291
Maria Paschalidis, D.o, D.O
Family Medicine — Payments: $10,936
Dr. Rogelio Allanigue, M.d, M.D
Family Medicine — Payments: $9,223